SENO SENORX, INC (SENO)

[VERYLONGSTOPPEDDRINKINGTHEKOOLAID]

Started my position today at $9.92...Looking like an OUTSTANDING LONG TERM PROPOSITION HERE with EXPLOSIVE GROWTH POTENTIAL!


New breast cancer treatment using balloon brachytherapy. Because the competition has used a uni-lumen approach only about 5% of the potential breast cancer candidates have been eligible for this procedure. What SenoRX (SENO) has developed with a multi-lumen approach, according to investigator radiation oncologists is that now 25% of the breast cancer patients will be eligible for treatment and a greatly expanded market of $75-$100 Million shall be created.

SenoRx is performing pre-launch activities for its balloon through 2007, in preparation for full commercial launch in 2008. The balloon is being introduced to select clinical sites where initial evaluation is being conducted prior to beginning further clinical and market testing studies.

FDA APPROVED!